Insightful portfolio adjustments in Q3 2024 highlight growth opportunities
T. Rowe Price Japan Fund (Trade, Portfolio), known for its strategic investments in Japan’s diverse industries, recently revealed its N-PORT filing for Q3 2024. The fund primarily targets companies that are poised to achieve the above goals. Invest at least 80% of your assets in line with average, long-term earnings growth. The investment team emphasizes a growth investment style and looks for companies with strong market positions, attractive niches and strong management teams. These choices are made with the aim of achieving sustainable long-term revenue growth, with a focus on financial health and market potential.
Strategic moves in the Japanese market: T. Rowe Price Japan Fund’s focus on Takeda Pharmaceutical
New strategic acquisition
T. Rowe Price Japan Fund (Trade, Portfolio) has expanded its portfolio by adding 10 new stocks. The following are noteworthy among them:
Takeda Pharmaceutical Company Limited (TSE: 4502) holds 239,500 shares, accounting for 2.4% of the portfolio, and has a market capitalization of 6.87 billion shares.
Komatsu Corporation (TSE:6301) consists of 150,500 shares, accounting for approximately 1.46% of the portfolio, and has a market capitalization of 4.17 billion.
Isuzu Motors Corporation (TSE:7202) holds 222,000 shares, accounting for 1.05% of the portfolio and totaling 2.99 billion shares.
Significant increase in position
The fund also significantly increased its stakes in several companies, including:
Nintendo Co., Ltd. (TSE: 7974) added 46,600 shares for a total of 158,100 shares. This adjustment represents a 41.79% increase in the number of shares, impacting the current portfolio of 8.44 billion shares by 0.87%.
Resona Holdings Co., Ltd. (TSE: 8308) added 187,800 shares for a total of 925,200 shares. This adjustment represents a 25.47% increase in the number of shares, totaling 6.45 billion shares.
Complete portfolio termination
The Fund fully exited positions in seven holdings during the third quarter of 2024, including:
All 161,800 shares of Daiichi Sankyo Co., Ltd. (TSE:4568) were sold, impacting the portfolio by -1.91%.
Suzuki Motor Corporation (TSE:7269) liquidated all 343,200 shares, impacting the portfolio by -1.36%.
Reduction of major assets held
In particular, several stocks saw significant price reductions, including:
Keyence Corporation (TSE:6861) was reduced by 10,600 shares, resulting in a -54.64% decrease in the number of shares and a -1.6% portfolio impact. The average price for the quarter was $67,965.6, with a return of -7.12% over the past three months and 11.25% year-to-date.
Tokyo Electron Ltd. (TSE:8035) experienced a decrease of 16,300 shares (-46.18%), impacting the portfolio by -1.22%. The average price for the quarter was $28,094.4, with a return of -24.32% over the past three months and 7.65% year-to-date.
story continues
Portfolio overview and focus areas
As of Q3 2024, the T. Rowe Price Japan Fund (Trade, Portfolio) portfolio includes 71 stocks. The top holding ratios are ITOCHU Corporation (TSE 8001) 5.93%, Sony Group Corporation (TSE 6758) 5.34%, Hitachi, Ltd. (TSE 6501) 4.52%, and Mitsubishi UFJ Financial Group, Inc. (TSE 8306) 4.46. %. ), 3.47% for Recruit Holdings (TSE: 6098). Its holdings are primarily concentrated in 10 industries, covering sectors from industrials to real estate.
Strategic moves in the Japanese market: T. Rowe Price Japan Fund’s focus on Takeda Pharmaceutical
Strategic moves in the Japanese market: T. Rowe Price Japan Fund’s focus on Takeda Pharmaceutical
This article created by GuruFocus is intended to provide general insight and is not intended as financial advice. Our commentary is based on historical data and analyst forecasts using an unbiased methodology and is not intended to serve as specific investment guidance. It does not constitute a recommendation to buy or sell stocks, and does not take into account your individual investment objectives or financial situation. Our objective is to provide fundamental data-driven analysis over time. Please note that our analysis may not incorporate the latest announcements or qualitative information from price-sensitive companies. GuruFocus has no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
